Case Report
Copyright ©The Author(s) 2022.
World J Clin Cases. Jun 6, 2022; 10(16): 5446-5455
Published online Jun 6, 2022. doi: 10.12998/wjcc.v10.i16.5446
Table 1 Motivational interviewing case management genotyping of the cases
Number
Age
Sex
FABtyping
Karyotype
Immunological phenotype
Genemutation
Therapeutic reaction
Prognosis
Ref.
127FM3i(17)(q10)CD33+/CD13+/ MPOPML-RARa (-)Retinoic acid (-)Die (survival 1 mo)Yan et al[15], China
210MM3i(17)(q10)--NRDie (survival < 1 mo)Bernstein et al[14], South Africa
3ChildF-i(17)(q10)----Raimondi et al[13], Mexico
4--M3i(17)(q10)----Becher et al[19]
53 (Case 1)MM3i(17)(q10)CD9/CD13/CD33/ CD38/CD64/CD123/CD58/MPOWT1/EP300/C.854delG: P w285fs Frame shiftC.C2102T: P.701LMissense-Wen JQ, China
612 (Case 2)MM3i(17)(q10) Add(14) (p11)CD9/CD13/CD33/ CD38/CD64/CD123/CD15/MPOWT1/TAL1/TTN/DDX11+CR 36 months, WT1 copy: 1010-1087Wen JQ, China